nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprostadil—SLCO3A1—Methotrexate—lung cancer	0.174	0.319	CbGbCtD
Alprostadil—ABCC5—Cisplatin—lung cancer	0.171	0.314	CbGbCtD
Alprostadil—SLCO2B1—Erlotinib—lung cancer	0.146	0.268	CbGbCtD
Alprostadil—ABCC4—Methotrexate—lung cancer	0.0535	0.098	CbGbCtD
Alprostadil—PTGIR—pulmonary artery—lung cancer	0.0199	0.229	CbGeAlD
Alprostadil—PTGER2—trachea—lung cancer	0.00423	0.0486	CbGeAlD
Alprostadil—ABCC5—mammary gland—lung cancer	0.00402	0.0462	CbGeAlD
Alprostadil—PTGER2—bone marrow—lung cancer	0.00335	0.0386	CbGeAlD
Alprostadil—PTGIR—respiratory system—lung cancer	0.00335	0.0385	CbGeAlD
Alprostadil—SLCO2B1—mammary gland—lung cancer	0.00314	0.0362	CbGeAlD
Alprostadil—PTGER2—lung—lung cancer	0.00304	0.0349	CbGeAlD
Alprostadil—SLCO2A1—respiratory system—lung cancer	0.00293	0.0337	CbGeAlD
Alprostadil—PTGIR—epithelium—lung cancer	0.0028	0.0322	CbGeAlD
Alprostadil—SLCO2A1—epithelium—lung cancer	0.00245	0.0282	CbGeAlD
Alprostadil—SLCO3A1—bronchus—lung cancer	0.00243	0.028	CbGeAlD
Alprostadil—SLCO2A1—bronchus—lung cancer	0.00241	0.0277	CbGeAlD
Alprostadil—Dinoprost Tromethamine—HPGDS—lung cancer	0.00223	0.411	CrCbGaD
Alprostadil—ABCC5—bronchus—lung cancer	0.0022	0.0254	CbGeAlD
Alprostadil—SLCO2A1—trachea—lung cancer	0.00216	0.0249	CbGeAlD
Alprostadil—SLCO2B1—respiratory system—lung cancer	0.0021	0.0241	CbGeAlD
Alprostadil—PTGER2—lymph node—lung cancer	0.00208	0.0239	CbGeAlD
Alprostadil—SLCO3A1—cardiac atrium—lung cancer	0.00205	0.0236	CbGeAlD
Alprostadil—SLCO2A1—cardiac atrium—lung cancer	0.00203	0.0234	CbGeAlD
Alprostadil—ABCC5—cardiac atrium—lung cancer	0.00186	0.0214	CbGeAlD
Alprostadil—PTGIR—lung—lung cancer	0.00178	0.0205	CbGeAlD
Alprostadil—Dinoprostone—HPGDS—lung cancer	0.00172	0.316	CrCbGaD
Alprostadil—SLCO3A1—lung—lung cancer	0.00157	0.0181	CbGeAlD
Alprostadil—ABCC5—bone marrow—lung cancer	0.00157	0.0181	CbGeAlD
Alprostadil—SLCO2A1—lung—lung cancer	0.00155	0.0179	CbGeAlD
Alprostadil—ABCC4—bronchus—lung cancer	0.00153	0.0176	CbGeAlD
Alprostadil—ABCC5—lung—lung cancer	0.00142	0.0164	CbGeAlD
Alprostadil—PTGIR—lymph node—lung cancer	0.00122	0.014	CbGeAlD
Alprostadil—SLCO2B1—lung—lung cancer	0.00111	0.0128	CbGeAlD
Alprostadil—ABCC4—bone marrow—lung cancer	0.00109	0.0125	CbGeAlD
Alprostadil—SLCO3A1—lymph node—lung cancer	0.00107	0.0124	CbGeAlD
Alprostadil—SLCO2A1—lymph node—lung cancer	0.00106	0.0122	CbGeAlD
Alprostadil—ABCC4—lung—lung cancer	0.000985	0.0113	CbGeAlD
Alprostadil—ABCC5—lymph node—lung cancer	0.000972	0.0112	CbGeAlD
Alprostadil—Ethanolamine Oleate—CYP2E1—lung cancer	0.000814	0.15	CrCbGaD
Alprostadil—SLCO2B1—lymph node—lung cancer	0.000761	0.00876	CbGeAlD
Alprostadil—ABCC4—lymph node—lung cancer	0.000674	0.00776	CbGeAlD
Alprostadil—Dihomo-gamma-linolenic acid—PTGS2—lung cancer	0.000663	0.122	CrCbGaD
Alprostadil—Hypoaesthesia—Docetaxel—lung cancer	0.000187	0.000869	CcSEcCtD
Alprostadil—Cardiac failure congestive—Doxorubicin—lung cancer	0.000187	0.000869	CcSEcCtD
Alprostadil—Infection—Gemcitabine—lung cancer	0.000187	0.000869	CcSEcCtD
Alprostadil—Hyperhidrosis—Irinotecan—lung cancer	0.000187	0.000868	CcSEcCtD
Alprostadil—Back pain—Paclitaxel—lung cancer	0.000187	0.000868	CcSEcCtD
Alprostadil—Pharyngitis—Docetaxel—lung cancer	0.000187	0.000867	CcSEcCtD
Alprostadil—Dizziness—Vinblastine—lung cancer	0.000186	0.000866	CcSEcCtD
Alprostadil—Convulsion—Cisplatin—lung cancer	0.000186	0.000865	CcSEcCtD
Alprostadil—Muscle spasms—Paclitaxel—lung cancer	0.000186	0.000863	CcSEcCtD
Alprostadil—Diarrhoea—Erlotinib—lung cancer	0.000185	0.000862	CcSEcCtD
Alprostadil—Abdominal pain—Vinorelbine—lung cancer	0.000185	0.000861	CcSEcCtD
Alprostadil—Body temperature increased—Vinorelbine—lung cancer	0.000185	0.000861	CcSEcCtD
Alprostadil—Urethral disorder—Docetaxel—lung cancer	0.000184	0.000856	CcSEcCtD
Alprostadil—Thrombocytopenia—Gemcitabine—lung cancer	0.000184	0.000856	CcSEcCtD
Alprostadil—Skin disorder—Gemcitabine—lung cancer	0.000183	0.00085	CcSEcCtD
Alprostadil—Anaemia—Etoposide—lung cancer	0.000182	0.000846	CcSEcCtD
Alprostadil—Hyperhidrosis—Gemcitabine—lung cancer	0.000182	0.000846	CcSEcCtD
Alprostadil—Visual impairment—Docetaxel—lung cancer	0.000181	0.000842	CcSEcCtD
Alprostadil—Dizziness—Topotecan—lung cancer	0.000181	0.000842	CcSEcCtD
Alprostadil—Discomfort—Cisplatin—lung cancer	0.000181	0.00084	CcSEcCtD
Alprostadil—Hypotension—Irinotecan—lung cancer	0.000181	0.000839	CcSEcCtD
Alprostadil—Dizziness—Erlotinib—lung cancer	0.000179	0.000833	CcSEcCtD
Alprostadil—Anaemia—Paclitaxel—lung cancer	0.000178	0.000829	CcSEcCtD
Alprostadil—Headache—Vinblastine—lung cancer	0.000177	0.000821	CcSEcCtD
Alprostadil—Hypotension—Gemcitabine—lung cancer	0.000176	0.000817	CcSEcCtD
Alprostadil—Oedema—Cisplatin—lung cancer	0.000175	0.000815	CcSEcCtD
Alprostadil—Flushing—Docetaxel—lung cancer	0.000174	0.000811	CcSEcCtD
Alprostadil—Infection—Cisplatin—lung cancer	0.000174	0.00081	CcSEcCtD
Alprostadil—Hypoglycaemia—Doxorubicin—lung cancer	0.000174	0.000808	CcSEcCtD
Alprostadil—Syncope—Paclitaxel—lung cancer	0.000173	0.000805	CcSEcCtD
Alprostadil—Loss of consciousness—Etoposide—lung cancer	0.000173	0.000804	CcSEcCtD
Alprostadil—Lethargy—Doxorubicin—lung cancer	0.000173	0.000804	CcSEcCtD
Alprostadil—Rash—Topotecan—lung cancer	0.000173	0.000802	CcSEcCtD
Alprostadil—Dermatitis—Topotecan—lung cancer	0.000173	0.000802	CcSEcCtD
Alprostadil—Cough—Etoposide—lung cancer	0.000172	0.000799	CcSEcCtD
Alprostadil—Thrombocytopenia—Cisplatin—lung cancer	0.000172	0.000798	CcSEcCtD
Alprostadil—Headache—Topotecan—lung cancer	0.000172	0.000797	CcSEcCtD
Alprostadil—Tachycardia—Cisplatin—lung cancer	0.000171	0.000796	CcSEcCtD
Alprostadil—Rash—Erlotinib—lung cancer	0.000171	0.000794	CcSEcCtD
Alprostadil—Dermatitis—Erlotinib—lung cancer	0.000171	0.000793	CcSEcCtD
Alprostadil—Convulsion—Etoposide—lung cancer	0.000171	0.000793	CcSEcCtD
Alprostadil—Skin disorder—Cisplatin—lung cancer	0.00017	0.000792	CcSEcCtD
Alprostadil—Dyspepsia—Irinotecan—lung cancer	0.00017	0.00079	CcSEcCtD
Alprostadil—Hypertension—Etoposide—lung cancer	0.00017	0.00079	CcSEcCtD
Alprostadil—Headache—Erlotinib—lung cancer	0.00017	0.000789	CcSEcCtD
Alprostadil—Loss of consciousness—Paclitaxel—lung cancer	0.00017	0.000789	CcSEcCtD
Alprostadil—Pain in extremity—Doxorubicin—lung cancer	0.00017	0.000788	CcSEcCtD
Alprostadil—Hyperhidrosis—Cisplatin—lung cancer	0.00017	0.000788	CcSEcCtD
Alprostadil—Cough—Paclitaxel—lung cancer	0.000168	0.000783	CcSEcCtD
Alprostadil—Asthenia—Vinorelbine—lung cancer	0.000168	0.000781	CcSEcCtD
Alprostadil—Nausea—Vinblastine—lung cancer	0.000167	0.000778	CcSEcCtD
Alprostadil—Convulsion—Paclitaxel—lung cancer	0.000167	0.000777	CcSEcCtD
Alprostadil—Hypertension—Paclitaxel—lung cancer	0.000167	0.000775	CcSEcCtD
Alprostadil—Pruritus—Vinorelbine—lung cancer	0.000166	0.00077	CcSEcCtD
Alprostadil—Discomfort—Etoposide—lung cancer	0.000166	0.00077	CcSEcCtD
Alprostadil—Pain—Irinotecan—lung cancer	0.000165	0.000768	CcSEcCtD
Alprostadil—Hypotension—Cisplatin—lung cancer	0.000164	0.000762	CcSEcCtD
Alprostadil—Erythema—Docetaxel—lung cancer	0.000164	0.000761	CcSEcCtD
Alprostadil—Nausea—Topotecan—lung cancer	0.000163	0.000756	CcSEcCtD
Alprostadil—Discomfort—Paclitaxel—lung cancer	0.000162	0.000755	CcSEcCtD
Alprostadil—Cardiac arrest—Doxorubicin—lung cancer	0.000161	0.000749	CcSEcCtD
Alprostadil—Pain—Gemcitabine—lung cancer	0.000161	0.000748	CcSEcCtD
Alprostadil—Nausea—Erlotinib—lung cancer	0.000161	0.000748	CcSEcCtD
Alprostadil—Dry mouth—Paclitaxel—lung cancer	0.000161	0.000747	CcSEcCtD
Alprostadil—Diarrhoea—Vinorelbine—lung cancer	0.00016	0.000745	CcSEcCtD
Alprostadil—Infection—Etoposide—lung cancer	0.00016	0.000742	CcSEcCtD
Alprostadil—Feeling abnormal—Irinotecan—lung cancer	0.000159	0.00074	CcSEcCtD
Alprostadil—Blood creatinine increased—Doxorubicin—lung cancer	0.000159	0.000738	CcSEcCtD
Alprostadil—Back pain—Docetaxel—lung cancer	0.000158	0.000736	CcSEcCtD
Alprostadil—Oedema—Paclitaxel—lung cancer	0.000158	0.000732	CcSEcCtD
Alprostadil—Thrombocytopenia—Etoposide—lung cancer	0.000157	0.000731	CcSEcCtD
Alprostadil—Muscle spasms—Docetaxel—lung cancer	0.000157	0.000731	CcSEcCtD
Alprostadil—Upper respiratory tract infection—Methotrexate—lung cancer	0.000157	0.000731	CcSEcCtD
Alprostadil—Tachycardia—Etoposide—lung cancer	0.000157	0.000729	CcSEcCtD
Alprostadil—Infection—Paclitaxel—lung cancer	0.000157	0.000728	CcSEcCtD
Alprostadil—Skin disorder—Etoposide—lung cancer	0.000156	0.000725	CcSEcCtD
Alprostadil—Hyperhidrosis—Etoposide—lung cancer	0.000155	0.000722	CcSEcCtD
Alprostadil—Feeling abnormal—Gemcitabine—lung cancer	0.000155	0.000721	CcSEcCtD
Alprostadil—Shock—Paclitaxel—lung cancer	0.000155	0.00072	CcSEcCtD
Alprostadil—Dizziness—Vinorelbine—lung cancer	0.000155	0.00072	CcSEcCtD
Alprostadil—Hypokalaemia—Doxorubicin—lung cancer	0.000154	0.000717	CcSEcCtD
Alprostadil—Thrombocytopenia—Paclitaxel—lung cancer	0.000154	0.000717	CcSEcCtD
Alprostadil—Tachycardia—Paclitaxel—lung cancer	0.000154	0.000715	CcSEcCtD
Alprostadil—Skin disorder—Paclitaxel—lung cancer	0.000153	0.000711	CcSEcCtD
Alprostadil—Abdominal pain—Irinotecan—lung cancer	0.000153	0.00071	CcSEcCtD
Alprostadil—Body temperature increased—Irinotecan—lung cancer	0.000153	0.00071	CcSEcCtD
Alprostadil—Hyperhidrosis—Paclitaxel—lung cancer	0.000152	0.000708	CcSEcCtD
Alprostadil—Anaemia—Docetaxel—lung cancer	0.000151	0.000703	CcSEcCtD
Alprostadil—Hypotension—Etoposide—lung cancer	0.00015	0.000698	CcSEcCtD
Alprostadil—Pain—Cisplatin—lung cancer	0.00015	0.000697	CcSEcCtD
Alprostadil—Body temperature increased—Gemcitabine—lung cancer	0.000149	0.000691	CcSEcCtD
Alprostadil—Renal failure—Methotrexate—lung cancer	0.000148	0.00069	CcSEcCtD
Alprostadil—Rash—Vinorelbine—lung cancer	0.000148	0.000686	CcSEcCtD
Alprostadil—Dermatitis—Vinorelbine—lung cancer	0.000148	0.000686	CcSEcCtD
Alprostadil—Hypotension—Paclitaxel—lung cancer	0.000147	0.000684	CcSEcCtD
Alprostadil—Headache—Vinorelbine—lung cancer	0.000147	0.000682	CcSEcCtD
Alprostadil—Syncope—Docetaxel—lung cancer	0.000147	0.000682	CcSEcCtD
Alprostadil—Influenza—Doxorubicin—lung cancer	0.000147	0.000681	CcSEcCtD
Alprostadil—Feeling abnormal—Cisplatin—lung cancer	0.000145	0.000672	CcSEcCtD
Alprostadil—Haematuria—Methotrexate—lung cancer	0.000144	0.000669	CcSEcCtD
Alprostadil—Loss of consciousness—Docetaxel—lung cancer	0.000144	0.000668	CcSEcCtD
Alprostadil—Cough—Docetaxel—lung cancer	0.000143	0.000664	CcSEcCtD
Alprostadil—Convulsion—Docetaxel—lung cancer	0.000142	0.000659	CcSEcCtD
Alprostadil—Hypertension—Docetaxel—lung cancer	0.000141	0.000657	CcSEcCtD
Alprostadil—Bronchitis—Doxorubicin—lung cancer	0.000141	0.000655	CcSEcCtD
Alprostadil—Nausea—Vinorelbine—lung cancer	0.000139	0.000647	CcSEcCtD
Alprostadil—Dyspepsia—Paclitaxel—lung cancer	0.000139	0.000645	CcSEcCtD
Alprostadil—Body temperature increased—Cisplatin—lung cancer	0.000139	0.000644	CcSEcCtD
Alprostadil—Asthenia—Irinotecan—lung cancer	0.000139	0.000644	CcSEcCtD
Alprostadil—Pain—Etoposide—lung cancer	0.000137	0.000639	CcSEcCtD
Alprostadil—Dry mouth—Docetaxel—lung cancer	0.000136	0.000633	CcSEcCtD
Alprostadil—Upper respiratory tract infection—Doxorubicin—lung cancer	0.000136	0.000633	CcSEcCtD
Alprostadil—Haemoglobin—Methotrexate—lung cancer	0.000136	0.000633	CcSEcCtD
Alprostadil—Haemorrhage—Methotrexate—lung cancer	0.000136	0.00063	CcSEcCtD
Alprostadil—Pollakiuria—Doxorubicin—lung cancer	0.000135	0.000629	CcSEcCtD
Alprostadil—Asthenia—Gemcitabine—lung cancer	0.000135	0.000628	CcSEcCtD
Alprostadil—Pain—Paclitaxel—lung cancer	0.000135	0.000626	CcSEcCtD
Alprostadil—Pharyngitis—Methotrexate—lung cancer	0.000134	0.000625	CcSEcCtD
Alprostadil—Oedema—Docetaxel—lung cancer	0.000134	0.000621	CcSEcCtD
Alprostadil—Pruritus—Gemcitabine—lung cancer	0.000133	0.000619	CcSEcCtD
Alprostadil—Urethral disorder—Methotrexate—lung cancer	0.000133	0.000617	CcSEcCtD
Alprostadil—Infection—Docetaxel—lung cancer	0.000133	0.000617	CcSEcCtD
Alprostadil—Feeling abnormal—Etoposide—lung cancer	0.000132	0.000615	CcSEcCtD
Alprostadil—Hyperglycaemia—Doxorubicin—lung cancer	0.000132	0.000614	CcSEcCtD
Alprostadil—Diarrhoea—Irinotecan—lung cancer	0.000132	0.000614	CcSEcCtD
Alprostadil—Shock—Docetaxel—lung cancer	0.000131	0.000611	CcSEcCtD
Alprostadil—Thrombocytopenia—Docetaxel—lung cancer	0.000131	0.000608	CcSEcCtD
Alprostadil—Visual impairment—Methotrexate—lung cancer	0.000131	0.000607	CcSEcCtD
Alprostadil—Tachycardia—Docetaxel—lung cancer	0.00013	0.000606	CcSEcCtD
Alprostadil—Feeling abnormal—Paclitaxel—lung cancer	0.00013	0.000603	CcSEcCtD
Alprostadil—Skin disorder—Docetaxel—lung cancer	0.00013	0.000603	CcSEcCtD
Alprostadil—Diarrhoea—Gemcitabine—lung cancer	0.000129	0.000598	CcSEcCtD
Alprostadil—Renal failure—Doxorubicin—lung cancer	0.000128	0.000597	CcSEcCtD
Alprostadil—Dizziness—Irinotecan—lung cancer	0.000128	0.000594	CcSEcCtD
Alprostadil—Body temperature increased—Etoposide—lung cancer	0.000127	0.00059	CcSEcCtD
Alprostadil—Abdominal pain—Etoposide—lung cancer	0.000127	0.00059	CcSEcCtD
Alprostadil—Urinary tract infection—Doxorubicin—lung cancer	0.000127	0.00059	CcSEcCtD
Alprostadil—Asthenia—Cisplatin—lung cancer	0.000126	0.000585	CcSEcCtD
Alprostadil—Hypotension—Docetaxel—lung cancer	0.000125	0.00058	CcSEcCtD
Alprostadil—Haematuria—Doxorubicin—lung cancer	0.000125	0.000579	CcSEcCtD
Alprostadil—Body temperature increased—Paclitaxel—lung cancer	0.000125	0.000579	CcSEcCtD
Alprostadil—Abdominal pain—Paclitaxel—lung cancer	0.000125	0.000579	CcSEcCtD
Alprostadil—Sinusitis—Doxorubicin—lung cancer	0.000123	0.00057	CcSEcCtD
Alprostadil—Rash—Irinotecan—lung cancer	0.000122	0.000566	CcSEcCtD
Alprostadil—Dermatitis—Irinotecan—lung cancer	0.000122	0.000566	CcSEcCtD
Alprostadil—Headache—Irinotecan—lung cancer	0.000121	0.000563	CcSEcCtD
Alprostadil—Diarrhoea—Cisplatin—lung cancer	0.00012	0.000558	CcSEcCtD
Alprostadil—Bradycardia—Doxorubicin—lung cancer	0.000119	0.000555	CcSEcCtD
Alprostadil—Rash—Gemcitabine—lung cancer	0.000119	0.000551	CcSEcCtD
Alprostadil—Dermatitis—Gemcitabine—lung cancer	0.000119	0.000551	CcSEcCtD
Alprostadil—Erythema—Methotrexate—lung cancer	0.000118	0.000548	CcSEcCtD
Alprostadil—Haemoglobin—Doxorubicin—lung cancer	0.000118	0.000548	CcSEcCtD
Alprostadil—Headache—Gemcitabine—lung cancer	0.000118	0.000548	CcSEcCtD
Alprostadil—Rhinitis—Doxorubicin—lung cancer	0.000118	0.000547	CcSEcCtD
Alprostadil—Dyspepsia—Docetaxel—lung cancer	0.000118	0.000546	CcSEcCtD
Alprostadil—Haemorrhage—Doxorubicin—lung cancer	0.000117	0.000545	CcSEcCtD
Alprostadil—Hypoaesthesia—Doxorubicin—lung cancer	0.000117	0.000543	CcSEcCtD
Alprostadil—Pharyngitis—Doxorubicin—lung cancer	0.000116	0.000541	CcSEcCtD
Alprostadil—Asthenia—Etoposide—lung cancer	0.000115	0.000536	CcSEcCtD
Alprostadil—Urethral disorder—Doxorubicin—lung cancer	0.000115	0.000534	CcSEcCtD
Alprostadil—Nausea—Irinotecan—lung cancer	0.000115	0.000533	CcSEcCtD
Alprostadil—Pain—Docetaxel—lung cancer	0.000114	0.000531	CcSEcCtD
Alprostadil—Back pain—Methotrexate—lung cancer	0.000114	0.00053	CcSEcCtD
Alprostadil—Pruritus—Etoposide—lung cancer	0.000114	0.000528	CcSEcCtD
Alprostadil—Visual impairment—Doxorubicin—lung cancer	0.000113	0.000525	CcSEcCtD
Alprostadil—Asthenia—Paclitaxel—lung cancer	0.000113	0.000525	CcSEcCtD
Alprostadil—Nausea—Gemcitabine—lung cancer	0.000112	0.00052	CcSEcCtD
Alprostadil—Pruritus—Paclitaxel—lung cancer	0.000111	0.000518	CcSEcCtD
Alprostadil—Rash—Cisplatin—lung cancer	0.000111	0.000514	CcSEcCtD
Alprostadil—Dermatitis—Cisplatin—lung cancer	0.000111	0.000514	CcSEcCtD
Alprostadil—Feeling abnormal—Docetaxel—lung cancer	0.00011	0.000511	CcSEcCtD
Alprostadil—Diarrhoea—Etoposide—lung cancer	0.00011	0.000511	CcSEcCtD
Alprostadil—Anaemia—Methotrexate—lung cancer	0.000109	0.000507	CcSEcCtD
Alprostadil—Flushing—Doxorubicin—lung cancer	0.000109	0.000506	CcSEcCtD
Alprostadil—Diarrhoea—Paclitaxel—lung cancer	0.000108	0.000501	CcSEcCtD
Alprostadil—Dizziness—Etoposide—lung cancer	0.000106	0.000494	CcSEcCtD
Alprostadil—Body temperature increased—Docetaxel—lung cancer	0.000106	0.000491	CcSEcCtD
Alprostadil—Abdominal pain—Docetaxel—lung cancer	0.000106	0.000491	CcSEcCtD
Alprostadil—Dizziness—Paclitaxel—lung cancer	0.000104	0.000484	CcSEcCtD
Alprostadil—Nausea—Cisplatin—lung cancer	0.000104	0.000484	CcSEcCtD
Alprostadil—Cough—Methotrexate—lung cancer	0.000103	0.000478	CcSEcCtD
Alprostadil—Convulsion—Methotrexate—lung cancer	0.000102	0.000475	CcSEcCtD
Alprostadil—Erythema—Doxorubicin—lung cancer	0.000102	0.000475	CcSEcCtD
Alprostadil—Rash—Etoposide—lung cancer	0.000101	0.000471	CcSEcCtD
Alprostadil—Dermatitis—Etoposide—lung cancer	0.000101	0.00047	CcSEcCtD
Alprostadil—Headache—Etoposide—lung cancer	0.000101	0.000468	CcSEcCtD
Alprostadil—Rash—Paclitaxel—lung cancer	9.94e-05	0.000462	CcSEcCtD
Alprostadil—Dermatitis—Paclitaxel—lung cancer	9.93e-05	0.000461	CcSEcCtD
Alprostadil—Discomfort—Methotrexate—lung cancer	9.92e-05	0.000461	CcSEcCtD
Alprostadil—Nervousness—Doxorubicin—lung cancer	9.92e-05	0.000461	CcSEcCtD
Alprostadil—Back pain—Doxorubicin—lung cancer	9.88e-05	0.000459	CcSEcCtD
Alprostadil—Headache—Paclitaxel—lung cancer	9.87e-05	0.000459	CcSEcCtD
Alprostadil—Muscle spasms—Doxorubicin—lung cancer	9.82e-05	0.000456	CcSEcCtD
Alprostadil—Asthenia—Docetaxel—lung cancer	9.58e-05	0.000445	CcSEcCtD
Alprostadil—Infection—Methotrexate—lung cancer	9.56e-05	0.000444	CcSEcCtD
Alprostadil—Nausea—Etoposide—lung cancer	9.55e-05	0.000444	CcSEcCtD
Alprostadil—Pruritus—Docetaxel—lung cancer	9.45e-05	0.000439	CcSEcCtD
Alprostadil—Anaemia—Doxorubicin—lung cancer	9.44e-05	0.000439	CcSEcCtD
Alprostadil—Thrombocytopenia—Methotrexate—lung cancer	9.43e-05	0.000438	CcSEcCtD
Alprostadil—Nausea—Paclitaxel—lung cancer	9.36e-05	0.000435	CcSEcCtD
Alprostadil—Skin disorder—Methotrexate—lung cancer	9.35e-05	0.000435	CcSEcCtD
Alprostadil—Hyperhidrosis—Methotrexate—lung cancer	9.31e-05	0.000432	CcSEcCtD
Alprostadil—Syncope—Doxorubicin—lung cancer	9.16e-05	0.000426	CcSEcCtD
Alprostadil—Diarrhoea—Docetaxel—lung cancer	9.14e-05	0.000425	CcSEcCtD
Alprostadil—Hypotension—Methotrexate—lung cancer	9e-05	0.000418	CcSEcCtD
Alprostadil—Loss of consciousness—Doxorubicin—lung cancer	8.98e-05	0.000417	CcSEcCtD
Alprostadil—Cough—Doxorubicin—lung cancer	8.91e-05	0.000414	CcSEcCtD
Alprostadil—Convulsion—Doxorubicin—lung cancer	8.85e-05	0.000411	CcSEcCtD
Alprostadil—Dizziness—Docetaxel—lung cancer	8.83e-05	0.00041	CcSEcCtD
Alprostadil—Hypertension—Doxorubicin—lung cancer	8.82e-05	0.00041	CcSEcCtD
Alprostadil—Discomfort—Doxorubicin—lung cancer	8.59e-05	0.000399	CcSEcCtD
Alprostadil—Dry mouth—Doxorubicin—lung cancer	8.5e-05	0.000395	CcSEcCtD
Alprostadil—Dyspepsia—Methotrexate—lung cancer	8.47e-05	0.000394	CcSEcCtD
Alprostadil—Rash—Docetaxel—lung cancer	8.42e-05	0.000391	CcSEcCtD
Alprostadil—Dermatitis—Docetaxel—lung cancer	8.41e-05	0.000391	CcSEcCtD
Alprostadil—Headache—Docetaxel—lung cancer	8.37e-05	0.000389	CcSEcCtD
Alprostadil—Oedema—Doxorubicin—lung cancer	8.34e-05	0.000387	CcSEcCtD
Alprostadil—Infection—Doxorubicin—lung cancer	8.28e-05	0.000385	CcSEcCtD
Alprostadil—Pain—Methotrexate—lung cancer	8.23e-05	0.000383	CcSEcCtD
Alprostadil—Shock—Doxorubicin—lung cancer	8.2e-05	0.000381	CcSEcCtD
Alprostadil—Thrombocytopenia—Doxorubicin—lung cancer	8.16e-05	0.000379	CcSEcCtD
Alprostadil—Tachycardia—Doxorubicin—lung cancer	8.14e-05	0.000378	CcSEcCtD
Alprostadil—Skin disorder—Doxorubicin—lung cancer	8.1e-05	0.000376	CcSEcCtD
Alprostadil—Hyperhidrosis—Doxorubicin—lung cancer	8.06e-05	0.000374	CcSEcCtD
Alprostadil—Nausea—Docetaxel—lung cancer	7.93e-05	0.000369	CcSEcCtD
Alprostadil—Feeling abnormal—Methotrexate—lung cancer	7.93e-05	0.000369	CcSEcCtD
Alprostadil—Hypotension—Doxorubicin—lung cancer	7.79e-05	0.000362	CcSEcCtD
Alprostadil—Abdominal pain—Methotrexate—lung cancer	7.61e-05	0.000354	CcSEcCtD
Alprostadil—Body temperature increased—Methotrexate—lung cancer	7.61e-05	0.000354	CcSEcCtD
Alprostadil—Dyspepsia—Doxorubicin—lung cancer	7.34e-05	0.000341	CcSEcCtD
Alprostadil—Pain—Doxorubicin—lung cancer	7.13e-05	0.000331	CcSEcCtD
Alprostadil—Asthenia—Methotrexate—lung cancer	6.91e-05	0.000321	CcSEcCtD
Alprostadil—Feeling abnormal—Doxorubicin—lung cancer	6.87e-05	0.000319	CcSEcCtD
Alprostadil—Pruritus—Methotrexate—lung cancer	6.81e-05	0.000317	CcSEcCtD
Alprostadil—Abdominal pain—Doxorubicin—lung cancer	6.59e-05	0.000306	CcSEcCtD
Alprostadil—Body temperature increased—Doxorubicin—lung cancer	6.59e-05	0.000306	CcSEcCtD
Alprostadil—Diarrhoea—Methotrexate—lung cancer	6.59e-05	0.000306	CcSEcCtD
Alprostadil—Dizziness—Methotrexate—lung cancer	6.37e-05	0.000296	CcSEcCtD
Alprostadil—Rash—Methotrexate—lung cancer	6.07e-05	0.000282	CcSEcCtD
Alprostadil—Dermatitis—Methotrexate—lung cancer	6.06e-05	0.000282	CcSEcCtD
Alprostadil—Headache—Methotrexate—lung cancer	6.03e-05	0.00028	CcSEcCtD
Alprostadil—Asthenia—Doxorubicin—lung cancer	5.98e-05	0.000278	CcSEcCtD
Alprostadil—Pruritus—Doxorubicin—lung cancer	5.9e-05	0.000274	CcSEcCtD
Alprostadil—Nausea—Methotrexate—lung cancer	5.72e-05	0.000266	CcSEcCtD
Alprostadil—Diarrhoea—Doxorubicin—lung cancer	5.7e-05	0.000265	CcSEcCtD
Alprostadil—Dizziness—Doxorubicin—lung cancer	5.51e-05	0.000256	CcSEcCtD
Alprostadil—Rash—Doxorubicin—lung cancer	5.26e-05	0.000244	CcSEcCtD
Alprostadil—Dermatitis—Doxorubicin—lung cancer	5.25e-05	0.000244	CcSEcCtD
Alprostadil—Headache—Doxorubicin—lung cancer	5.22e-05	0.000243	CcSEcCtD
Alprostadil—Nausea—Doxorubicin—lung cancer	4.95e-05	0.00023	CcSEcCtD
Alprostadil—PTGIR—Hemostasis—KRAS—lung cancer	3.35e-05	0.000228	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—MAP2K1—lung cancer	3.35e-05	0.000228	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—MAP2K1—lung cancer	3.35e-05	0.000228	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—PIK3CD—lung cancer	3.33e-05	0.000226	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—PIK3CD—lung cancer	3.33e-05	0.000226	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—PIK3CG—lung cancer	3.31e-05	0.000225	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—APC—lung cancer	3.31e-05	0.000225	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—KIT—lung cancer	3.31e-05	0.000225	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—NRAS—lung cancer	3.31e-05	0.000225	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—CAT—lung cancer	3.28e-05	0.000223	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—EGF—lung cancer	3.27e-05	0.000223	CbGpPWpGaD
Alprostadil—ABCC5—Disease—TERT—lung cancer	3.26e-05	0.000222	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—AVP—lung cancer	3.2e-05	0.000218	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—AVP—lung cancer	3.2e-05	0.000218	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—PIK3CB—lung cancer	3.19e-05	0.000217	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—PIK3CB—lung cancer	3.19e-05	0.000217	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—ABCB1—lung cancer	3.19e-05	0.000217	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—MAPK3—lung cancer	3.17e-05	0.000216	CbGpPWpGaD
Alprostadil—ABCC5—Disease—FGFR1—lung cancer	3.16e-05	0.000215	CbGpPWpGaD
Alprostadil—ABCC4—Transmembrane transport of small molecules—CREBBP—lung cancer	3.15e-05	0.000215	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—POMC—lung cancer	3.15e-05	0.000214	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—TYMS—lung cancer	3.13e-05	0.000213	CbGpPWpGaD
Alprostadil—ABCC5—Disease—HIF1A—lung cancer	3.12e-05	0.000212	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—BRAF—lung cancer	3.11e-05	0.000212	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—GSTM1—lung cancer	3.1e-05	0.000211	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—RAF1—lung cancer	3.08e-05	0.00021	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—IGF1R—lung cancer	3.08e-05	0.00021	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—IGF1R—lung cancer	3.08e-05	0.00021	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—PIK3CA—lung cancer	3.08e-05	0.00021	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—IL6R—lung cancer	3.07e-05	0.000209	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—CXCL8—lung cancer	3.07e-05	0.000209	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—CXCL8—lung cancer	3.07e-05	0.000209	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CREBBP—lung cancer	3.07e-05	0.000209	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—HES1—lung cancer	3.03e-05	0.000206	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—HES1—lung cancer	3.03e-05	0.000206	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—EGFR—lung cancer	3.01e-05	0.000205	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—PIK3CB—lung cancer	3.01e-05	0.000205	CbGpPWpGaD
Alprostadil—ABCC5—Disease—APOA1—lung cancer	3.01e-05	0.000205	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—TP53—lung cancer	2.98e-05	0.000203	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—RAF1—lung cancer	2.97e-05	0.000202	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—RAF1—lung cancer	2.97e-05	0.000202	CbGpPWpGaD
Alprostadil—ABCC4—Transmembrane transport of small molecules—ALB—lung cancer	2.95e-05	0.000201	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—CYP1A1—lung cancer	2.93e-05	0.0002	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—IL2—lung cancer	2.93e-05	0.000199	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—IL2—lung cancer	2.93e-05	0.000199	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—MAP2K1—lung cancer	2.93e-05	0.000199	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—ERCC2—lung cancer	2.91e-05	0.000198	CbGpPWpGaD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—AKT1—lung cancer	2.91e-05	0.000198	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—PIK3CD—lung cancer	2.91e-05	0.000198	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—PIK3CB—lung cancer	2.9e-05	0.000197	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—PIK3CB—lung cancer	2.9e-05	0.000197	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—PIK3CA—lung cancer	2.88e-05	0.000196	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—HRAS—lung cancer	2.85e-05	0.000194	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—KRAS—lung cancer	2.85e-05	0.000194	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—CXCL8—lung cancer	2.79e-05	0.00019	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—CXCL8—lung cancer	2.79e-05	0.00019	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—ERBB3—lung cancer	2.77e-05	0.000188	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—ERBB3—lung cancer	2.77e-05	0.000188	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—IL2—lung cancer	2.77e-05	0.000188	CbGpPWpGaD
Alprostadil—ABCC5—Disease—APC—lung cancer	2.74e-05	0.000187	CbGpPWpGaD
Alprostadil—ABCC5—Disease—KIT—lung cancer	2.74e-05	0.000187	CbGpPWpGaD
Alprostadil—ABCC5—Disease—EGF—lung cancer	2.71e-05	0.000185	CbGpPWpGaD
Alprostadil—ABCC4—Transmembrane transport of small molecules—RAF1—lung cancer	2.67e-05	0.000182	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—IL2—lung cancer	2.66e-05	0.000181	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—IL2—lung cancer	2.66e-05	0.000181	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—TERT—lung cancer	2.65e-05	0.00018	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—TERT—lung cancer	2.65e-05	0.00018	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—PIK3CA—lung cancer	2.62e-05	0.000178	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—MDM2—lung cancer	2.61e-05	0.000177	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—RAF1—lung cancer	2.6e-05	0.000177	CbGpPWpGaD
Alprostadil—ABCC5—Disease—BRAF—lung cancer	2.58e-05	0.000176	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—FGFR1—lung cancer	2.58e-05	0.000175	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—FGFR1—lung cancer	2.58e-05	0.000175	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—ERBB2—lung cancer	2.57e-05	0.000175	CbGpPWpGaD
Alprostadil—ABCC5—Disease—IL6R—lung cancer	2.55e-05	0.000173	CbGpPWpGaD
Alprostadil—ABCC5—Disease—CREBBP—lung cancer	2.54e-05	0.000173	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—HIF1A—lung cancer	2.54e-05	0.000173	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—HIF1A—lung cancer	2.54e-05	0.000173	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—MTOR—lung cancer	2.54e-05	0.000173	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—PIK3CB—lung cancer	2.54e-05	0.000173	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—APOA1—lung cancer	2.52e-05	0.000171	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—AKT1—lung cancer	2.52e-05	0.000171	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—EP300—lung cancer	2.48e-05	0.000169	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—APOA1—lung cancer	2.45e-05	0.000167	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—APOA1—lung cancer	2.45e-05	0.000167	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CXCL8—lung cancer	2.44e-05	0.000166	CbGpPWpGaD
Alprostadil—ABCC5—Disease—MAP2K1—lung cancer	2.43e-05	0.000165	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—KDR—lung cancer	2.43e-05	0.000165	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—KDR—lung cancer	2.43e-05	0.000165	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—HRAS—lung cancer	2.42e-05	0.000165	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—SRC—lung cancer	2.41e-05	0.000164	CbGpPWpGaD
Alprostadil—ABCC5—Disease—PIK3CD—lung cancer	2.41e-05	0.000164	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—AKT1—lung cancer	2.35e-05	0.00016	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—VEGFA—lung cancer	2.35e-05	0.00016	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CASP3—lung cancer	2.33e-05	0.000159	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—IL2—lung cancer	2.33e-05	0.000158	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—NRAS—lung cancer	2.32e-05	0.000158	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—IL6—lung cancer	2.32e-05	0.000158	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—PIK3CG—lung cancer	2.3e-05	0.000156	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CCND1—lung cancer	2.27e-05	0.000154	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—JUN—lung cancer	2.27e-05	0.000154	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—APC—lung cancer	2.24e-05	0.000152	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PIK3CG—lung cancer	2.24e-05	0.000152	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—APC—lung cancer	2.24e-05	0.000152	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—KIT—lung cancer	2.24e-05	0.000152	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PIK3CG—lung cancer	2.24e-05	0.000152	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—KIT—lung cancer	2.24e-05	0.000152	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—NRAS—lung cancer	2.23e-05	0.000152	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—NRAS—lung cancer	2.23e-05	0.000152	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—MAPK3—lung cancer	2.22e-05	0.000151	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—EGF—lung cancer	2.21e-05	0.00015	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—EGF—lung cancer	2.21e-05	0.00015	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—MMP9—lung cancer	2.2e-05	0.00015	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CDKN1A—lung cancer	2.2e-05	0.000149	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—PTEN—lung cancer	2.19e-05	0.000149	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—POMC—lung cancer	2.19e-05	0.000149	CbGpPWpGaD
Alprostadil—ABCC5—Disease—MDM2—lung cancer	2.16e-05	0.000147	CbGpPWpGaD
Alprostadil—ABCC5—Disease—RAF1—lung cancer	2.15e-05	0.000147	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—MAPK3—lung cancer	2.14e-05	0.000146	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—MAPK3—lung cancer	2.14e-05	0.000146	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—AKT1—lung cancer	2.14e-05	0.000145	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—CREBBP—lung cancer	2.13e-05	0.000145	CbGpPWpGaD
Alprostadil—ABCC5—Disease—ERBB2—lung cancer	2.13e-05	0.000145	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—POMC—lung cancer	2.13e-05	0.000145	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—POMC—lung cancer	2.13e-05	0.000145	CbGpPWpGaD
Alprostadil—ABCC5—Disease—PIK3CB—lung cancer	2.1e-05	0.000143	CbGpPWpGaD
Alprostadil—ABCC5—Disease—MTOR—lung cancer	2.1e-05	0.000143	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—BRAF—lung cancer	2.1e-05	0.000143	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—BRAF—lung cancer	2.1e-05	0.000143	CbGpPWpGaD
Alprostadil—ABCC5—Disease—CD4—lung cancer	2.1e-05	0.000143	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—EP300—lung cancer	2.09e-05	0.000142	CbGpPWpGaD
Alprostadil—ABCC5—Disease—PTGS2—lung cancer	2.08e-05	0.000142	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—IL6R—lung cancer	2.08e-05	0.000141	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—IL6R—lung cancer	2.08e-05	0.000141	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CREBBP—lung cancer	2.07e-05	0.000141	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CREBBP—lung cancer	2.07e-05	0.000141	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—EGFR—lung cancer	2.04e-05	0.000139	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—EGFR—lung cancer	2.04e-05	0.000139	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—SRC—lung cancer	2.03e-05	0.000138	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—PIK3CD—lung cancer	2.02e-05	0.000137	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—KRAS—lung cancer	2e-05	0.000136	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—ALB—lung cancer	1.99e-05	0.000136	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—VEGFA—lung cancer	1.98e-05	0.000135	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—MAP2K1—lung cancer	1.98e-05	0.000135	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—MAP2K1—lung cancer	1.98e-05	0.000135	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PIK3CD—lung cancer	1.96e-05	0.000134	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PIK3CD—lung cancer	1.96e-05	0.000134	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—STAT3—lung cancer	1.96e-05	0.000133	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—NRAS—lung cancer	1.95e-05	0.000133	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—PIK3CA—lung cancer	1.95e-05	0.000132	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—PIK3CA—lung cancer	1.95e-05	0.000132	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—KRAS—lung cancer	1.92e-05	0.000131	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—KRAS—lung cancer	1.92e-05	0.000131	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—MAPK3—lung cancer	1.87e-05	0.000127	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—PIK3CA—lung cancer	1.84e-05	0.000125	CbGpPWpGaD
Alprostadil—ABCC5—Disease—CDKN1A—lung cancer	1.82e-05	0.000124	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—MYC—lung cancer	1.82e-05	0.000124	CbGpPWpGaD
Alprostadil—ABCC5—Disease—PTEN—lung cancer	1.82e-05	0.000124	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—EGFR—lung cancer	1.78e-05	0.000121	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—TP53—lung cancer	1.78e-05	0.000121	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—PIK3CA—lung cancer	1.77e-05	0.00012	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—PIK3CA—lung cancer	1.77e-05	0.00012	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—PIK3CB—lung cancer	1.76e-05	0.00012	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—MDM2—lung cancer	1.76e-05	0.00012	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—MDM2—lung cancer	1.76e-05	0.00012	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—RAF1—lung cancer	1.75e-05	0.000119	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—RAF1—lung cancer	1.75e-05	0.000119	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—PTGS2—lung cancer	1.75e-05	0.000119	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—ERBB2—lung cancer	1.74e-05	0.000118	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—ERBB2—lung cancer	1.74e-05	0.000118	CbGpPWpGaD
Alprostadil—ABCC5—Disease—EP300—lung cancer	1.73e-05	0.000118	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PIK3CB—lung cancer	1.71e-05	0.000117	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—MTOR—lung cancer	1.71e-05	0.000117	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—MTOR—lung cancer	1.71e-05	0.000117	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PIK3CB—lung cancer	1.71e-05	0.000117	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—HRAS—lung cancer	1.7e-05	0.000116	CbGpPWpGaD
Alprostadil—ABCC5—Disease—SRC—lung cancer	1.69e-05	0.000115	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—KRAS—lung cancer	1.68e-05	0.000114	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CXCL8—lung cancer	1.65e-05	0.000112	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CXCL8—lung cancer	1.65e-05	0.000112	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—HRAS—lung cancer	1.64e-05	0.000111	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—HRAS—lung cancer	1.64e-05	0.000111	CbGpPWpGaD
Alprostadil—ABCC5—Disease—STAT3—lung cancer	1.63e-05	0.000111	CbGpPWpGaD
Alprostadil—ABCC5—Disease—NRAS—lung cancer	1.62e-05	0.00011	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—AKT1—lung cancer	1.59e-05	0.000108	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—AKT1—lung cancer	1.59e-05	0.000108	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CASP3—lung cancer	1.58e-05	0.000107	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CASP3—lung cancer	1.58e-05	0.000107	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—IL2—lung cancer	1.57e-05	0.000107	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—IL2—lung cancer	1.57e-05	0.000107	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—IL6—lung cancer	1.56e-05	0.000106	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—IL6—lung cancer	1.56e-05	0.000106	CbGpPWpGaD
Alprostadil—ABCC5—Disease—MAPK3—lung cancer	1.55e-05	0.000106	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—PIK3CA—lung cancer	1.55e-05	0.000105	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CCND1—lung cancer	1.53e-05	0.000104	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CCND1—lung cancer	1.53e-05	0.000104	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—JUN—lung cancer	1.53e-05	0.000104	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—JUN—lung cancer	1.53e-05	0.000104	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—PTEN—lung cancer	1.52e-05	0.000104	CbGpPWpGaD
Alprostadil—ABCC5—Disease—MYC—lung cancer	1.51e-05	0.000103	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—AKT1—lung cancer	1.5e-05	0.000102	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—TP53—lung cancer	1.5e-05	0.000102	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—MMP9—lung cancer	1.49e-05	0.000101	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—MMP9—lung cancer	1.49e-05	0.000101	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CDKN1A—lung cancer	1.48e-05	0.000101	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CDKN1A—lung cancer	1.48e-05	0.000101	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PTEN—lung cancer	1.48e-05	0.000101	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PTEN—lung cancer	1.48e-05	0.000101	CbGpPWpGaD
Alprostadil—ABCC5—Disease—EGFR—lung cancer	1.48e-05	0.000101	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—EP300—lung cancer	1.45e-05	9.88e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—AKT1—lung cancer	1.44e-05	9.82e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—AKT1—lung cancer	1.44e-05	9.82e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—HRAS—lung cancer	1.43e-05	9.73e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—EP300—lung cancer	1.41e-05	9.6e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—EP300—lung cancer	1.41e-05	9.6e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—KRAS—lung cancer	1.4e-05	9.49e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—SRC—lung cancer	1.37e-05	9.34e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—SRC—lung cancer	1.37e-05	9.34e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—IL6—lung cancer	1.37e-05	9.31e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—VEGFA—lung cancer	1.34e-05	9.09e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—VEGFA—lung cancer	1.34e-05	9.09e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—STAT3—lung cancer	1.32e-05	9e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—STAT3—lung cancer	1.32e-05	9e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—NRAS—lung cancer	1.32e-05	8.98e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—NRAS—lung cancer	1.32e-05	8.98e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—PIK3CA—lung cancer	1.28e-05	8.72e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—MAPK3—lung cancer	1.26e-05	8.6e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—MAPK3—lung cancer	1.26e-05	8.6e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—AKT1—lung cancer	1.26e-05	8.59e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—MYC—lung cancer	1.23e-05	8.37e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—MYC—lung cancer	1.23e-05	8.37e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—EGFR—lung cancer	1.2e-05	8.18e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—EGFR—lung cancer	1.2e-05	8.18e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—HRAS—lung cancer	1.19e-05	8.07e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—KRAS—lung cancer	1.14e-05	7.73e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—KRAS—lung cancer	1.14e-05	7.73e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—IL6—lung cancer	1.14e-05	7.72e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—PIK3CA—lung cancer	1.07e-05	7.3e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—AKT1—lung cancer	1.05e-05	7.13e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PIK3CA—lung cancer	1.04e-05	7.1e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PIK3CA—lung cancer	1.04e-05	7.1e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—TP53—lung cancer	1.01e-05	6.87e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—TP53—lung cancer	1.01e-05	6.87e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—HRAS—lung cancer	9.66e-06	6.57e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—HRAS—lung cancer	9.66e-06	6.57e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—IL6—lung cancer	9.24e-06	6.29e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—IL6—lung cancer	9.24e-06	6.29e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—AKT1—lung cancer	8.77e-06	5.97e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—AKT1—lung cancer	8.53e-06	5.8e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—AKT1—lung cancer	8.53e-06	5.8e-05	CbGpPWpGaD
